Hey, it's great news. Their other products are already approved as class II devices in Canada however, so it's hardly unexpected that RX Recovery would get the same designation. I'm in the camp with others here that for BIEL it's FDA or bust. It's also typical of BIEL to release this type of PR on the same day that they release their less than stellar financial statements. Once the buzz dies down from this PR people will focus on the numbers, so IMO this is a good opportunity to do some trading. GL.
